Jeff Perl

This #ASNCJASN study analyzed data from over 26,000 individuals on peritoneal dialysis (PD) across eight countries to explore sex differences in treatment outcomes. Read more here: kidney.pub/CJASN0937 @edwinabrown-pd.bsky.social @pd-perls.bsky.social

@nehadebnath.bsky.social you guys were a fantastic group !! Such a pleasure the future of home dialysis is bright !!!

Check out our #PDExchange podcast newest episode: #Exercise & #PeritonealDialysis: Not a healthy "hobby", it's medical treatment!!

Moderators: @drnikhilshah.bsky.social @pd-perls.bsky.social
Speakers:
Stephanie Thompson
Clara Bohm
Paul Bennett

@grexnetwork.bsky.social @ispd.org

Frailty Impact on Kidney Transplantation in Older People (KTOP) Kidney transplantation (KT) is increasing in older people. This cohort are vulnerable to frailty, which affects KT outcomes. This study investigated the impact of frailty on quality of life (QoL) and ...

Frailty Impact on Kidney Transplantation in Older People (KTOP) - Kidney International Reports www.kireports.org/article/S246.... Good to see published. A long journey but important info to guide older people expectations @kidneyresearchuk.org @kidneydoc101.bsky.social @pd-perls.bsky.social

@pd-perls.bsky.social and I, present the #PDEchange #podcast
#Exercise and #PeritonealDialysis - Not a healthy "hobby", its medical treatment!!
feat: Dr Stephanie Thompson, Dr Clara Bohm, Dr Paul Bennett

CC: @ispd.org @pdi-journal.bsky.social

Spotify - bit.ly/3UbmFLj
Apple - bit.ly/3WSA4d8

🚨 Big news! The @ispd.org journal #PeritonealDialysis International hits its highest-ever Impact Factor in 2024: JIF 3.7 ! 🎉

Huge thanks to @pd-perls.bsky.social, senior editorial team & all authors, reviewers & global #PDEnthusiasts. Your work is driving innovation in #KidneyCare!
buff.ly/ciy98Gs

I think it continues to endorse the safety of twice daily icodextrin but the study design and power may not be optimal to look at benefit which for me is reducing patient burden as a vehicle to doing less dialysis

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized ... FIND-CKD is the first phase 3 trial of finerenone in patients with CKD of non-diabetic aetiology.

hopefully supported by find-ckd trial

pubmed.ncbi.nlm.nih.gov/38858818/

Another great day of interviews with @kidneyboy.bsky.social at #NKFClinicals. Thanks to James Tumlin, Roger Rodby, @pd-perls.bsky.social, @areefishani.bsky.social, Bradley Marder, and Jayme Locke for their time. Keep an eye on our website for the conversations. #nephsky #nephrology buff.ly/SIWWB1p

Incremental PD needs data as well !!

Great slides but also excellent content discussing assessing quality of PD holistically and not by flawed equations @ispd.org @pd-perls.bsky.social

We are celebrating #WorldKidneyDay with our followers to raise awareness about kidney health #AreYourKidneysOK early diagnosis & prevention of kidney failure. Empowering patients for #peritonealdialysis when kidney replacement therapy is needed.
@ispd.org @pd-perls.bsky.social

On the occasion of the #InternationalWomensDay
@pd-perls.bsky.social and I chat with three extraordinary women in #peritonealdialysis on a new special episode of the #PDExchange #podcast
Podcast Link
Spotify - spoti.fi/3DxBOli
Apple - apple.co/3pboqwa

@ispd.org @pdi-journal.bsky.social

A Northwestern Medicine promotional poster for March 12, 2025 Medical Grand Rounds with special guest Jeffrey Perl, MD, SM, FRCP (C) with his talk entitled "Enhancing Personalized Medicine in Nephrology"

Please join us on Wednesday, March 12th at Noon for our Next Medical Grand Rounds! We will be joined by
@pd-perls.bsky.social from @unityhealthto.bsky.social @uoft.bsky.social !

#northwestern #northwesternmedicine #medicalgrandrounds #MedSky

📢 New Issue Alert March 2025
@pdi-journal.bsky.social , @ispd.org
🔗 buff.ly/Ode3kIM
Editor In Chief: @pd-perls.bsky.social
Visual Abstract: @edgarvlermamd.bsky.social , @jmteakell.bsky.social
Social Media Ed: @drnikhilshah.bsky.social
#PeritonealDialysis @SageJournals

Celebrating the Women in #PeritonealDialysis on this day of #InternationalDayofWomenandGirlsinScience #WomenInScience @pdi-journal.bsky.social @ispd.org
Podcast Link
Spotify - bit.ly/3iP1kbe
Apple - bit.ly/3WSA4d8

@un.org @unesco.org
@pd-perls.bsky.social

#PDExchange #Podcast
#WomenInNephrology

Celebrating International Women In Science Day (Feb 11) with Joanne Bargman, @edwinabrown-pd.bsky.social and
Ana Figueiredo.

@un.org @who.int
@ispd.org
@pd-perls.bsky.social
@drnikhilshah.bsky.social
Links
Spotify - bit.ly/3iP1kbe
Apple - bit.ly/3WSA4d8

Links to the podcast episode.

@pd-perls.bsky.social @ispd.org @pdi-journal.bsky.social

Spotify
buff.ly/40VmMih

Apple
buff.ly/3EiTVvD

The ELIXIR Trial and Xylocor Solution: Exploring the Future of Peritoneal Dialysis by The #PDExchange Podcast In the first PD Exchange podcast episode of 2025, Dr. Nikhil Shah and Dr. Jeff Perl introduce a groundbreaking topic—the ELIXIR trial aimed at evaluating Xylocor, an innovative glucose-sparing…

#PDExchange Podcast - New Episode
@pd-perls.bsky.social and @drnikhilshah.bsky.social dive into the groundbreaking ELIXIR trial protocol! Discover the potential of Xylocor, a novel solution for PD that could revolutionize treatment.

Spotify
https://buff.ly/40VmMih

Apple
https://buff.ly/3EiTVvD

Will Xylocore® be the magic ELIXIR for peritoneal dialysis?

@ispd.org @pdi-journal.bsky.social @drnikhilshah.bsky.social @pd-perls.bsky.social @mlambie.bsky.social

Editorial: journals.sagepub.com/eprint/ENYAN...

Original article: journals.sagepub.com/doi/10.1177/...

Nope we use the patients usual dwell volume

What better first post on blue sky then to congratulate a colleague and friend @uhnresearch.bsky.social @uoft.bsky.social Dr Christopher Chan on his Richard Yu endowed lectureship at ICCN2024 Hong Kong